Good evening,
 
 

Good evening,

If there’s one deal we can bank on this year, it’s a restructuring at KKR’s cancer care provider GenesisCare.

GenesisCare is lumped with more than $2 billion in debt and shareholder loans, and earnings that are yet to recover from the COVID-19 pandemic.

With debt to EBITDA hovering in the 18 to 20-times range for most of last year, the company’s under pressure to fix its capital structure. First port of call is to pay down debt.

GenesisCare has pulled a few triggers - selling its cardiology business, for example - but has further to go. The company’s considering funding proposals from a bunch of potential new investors, including distressed debt types.

Street Talk can reveal tonight that Oaktree Capital Management has lobbed a proposal, put together with help from Moelis, and is trying to find a way into the situation. Others are also on the scene, while GenesisCare and its two big shareholders KKR and China Resources have all called in their own bankers to help find a way through.

It’s one to watch in coming months. GenesisCare is a ripping Australian success story, that (in hindsight) went big in the US at the wrong time. It added a stack of debt, which now looks untenable.

There’s a good (and important) business at its heart - and that’s what’s attracting the likes of Oaktree.

Elsewhere, we look at FTI’s near term capital search for Sun Cable, and find a potential M&A situation unfolding at Mad Paws.

Happy reading,

Anthony Macdonald, Sarah Thompson and Kanika Sood

Street Talk Editors

 
The Australian Financial Review
TwitterInstagramLinkedInFacebook

You have received this email because you are subscribed to Street Talk First Look with the email address: newsletter@newslettercollector.com

  Manage Subscriptions     Unsubscribe     Privacy Policy     Contact Us  

© 2023 The Australian Financial Review

1 Denison Street North Sydney, NSW 2060 Australia

 
Nine Entertainment, 1 Denison St, North Sydney, NSW, 2060, Australia Profile center